NCT04688346View on ClinicalTrials.gov

Cardiovascular Effects of Racemic Epinephrine Pellets

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 10, 2019

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Epinephrine Causing Adverse Effects in Therapeutic Use
Interventions
DRUG

HemeRX epinephrine pellets

Racemic Epinephrine Pellet

Trial Locations (1)

98115

UW Center for Pediatric Dentistry, Seattle

All Listed Sponsors
lead

University of Washington

OTHER

NCT04688346 - Cardiovascular Effects of Racemic Epinephrine Pellets | Biotech Hunter | Biotech Hunter